Gilbert Honigfeld
Directeur Technique/Scientifique/R&D chez Alamo Pharmaceuticals LLC
Profil
Gilbert Honigfeld is Vice President of Scientific Affairs for Alamo Pharmaceuticals LLC.
Before that,he was a Principal at the Robert Wood Johnson Medical School and at the Institute for Health Care Research and Policy at Georgetown University Medical Center.
Previously, Dr. Honigfeld held several executive level positions at Novartis Pharmaceuticals Corporation and served as Director of Clinical Research, Director of Scientific Communications, and Director for Clozaril Product Marketing.
He received a BA degree in English and Psychology from Rutgers University, and an MA in General Psychology and a PhD in Clinical Psychology from Temple University.
Postes actifs de Gilbert Honigfeld
| Sociétés | Poste | Début |
|---|---|---|
Alamo Pharmaceuticals LLC
 Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Gilbert Honigfeld
| Sociétés | Poste | Fin |
|---|---|---|
| Georgetown University | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
Formation de Gilbert Honigfeld
| Rutgers State University of New Jersey | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Alamo Pharmaceuticals LLC
Alamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Alamo Pharmaceuticals LLC markets and develops pharmaceutical products. The company's product FazaClo (clozapine) is used to treat patients with severe schizophrenia. It is also testing the drug in conjunction with schizophrenia treatments to reduce the side effects of anti-psychotic drugs. The company was founded by Neal R. Cutler and is headquartered in Beverly Hills, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
